SIRPA and type 1 diabetes mellitus: Loss of SIRPα has been observed in the beta-cells of people with newly diagnosed T1D, resulting in a reduced ability of STAT1 to respond transcriptionally to pro-inflammatory cytokines, including IFN-γ.